Gene · 970
NIH grants2,135
NIH grants whose papers are about the gene, through NIH's grant-paper links.
201 to 220 of 2,135
Download this page as JSON| Grant | Title | CD70 papers | Newest fiscal year |
|---|---|---|---|
| P51OD011092 | Support for National Primate Research Center | 1 | 2025 |
| P51OD011104 | Tulane National Primate Research Center | 1 | 2025 |
| P51OD011132 | Emory National Primate Research Center | 1 | 2025 |
| R01AI040459 | Post-Transplant Inflammatory Response | 1 | 2025 |
| R01AI045050 | Characterization of SLE-susceptibility loci on mouse chromosome 1 | 1 | 2025 |
| R01AI066232 | Regulation of memory CD8 T cell development | 1 | 2025 |
| R01AI093615 | The role of γδ T cells in fetal and infant immune defense against malaria | 1 | 2025 |
| R01AI104870 | Discriminating the contributions of CCR4 and CCR7 to thymic central tolerance | 1 | 2025 |
| R01AI112579 | Regulation of T cell exhaustion via 3D chromatin architecture | 1 | 2025 |
| R01AI113142 | Designing induction therapies to target memory T cells in high risk recipients | 1 | 2025 |
| R01AI121080 | CTCF in CD8 T cell homeostasis and anti-viral/tumor immunity | 1 | 2025 |
| R01AI135049 | Understanding alpha-gal red meat allergy | 1 | 2025 |
| R01AI137276 | Mechanisms of Antibody-Dependent Enhancement of Dengue Disease | 1 | 2025 |
| R01AI145870 | Development of vaccination strategies to elicit broadly protective immunity against influenza | 1 | 2025 |
| R01AI150664 | Origin and Function of Double Negative T cells in Lupus | 1 | 2025 |
| R01AI156274 | Phosphorylation of TSC2 (S1365) as a novel Regulator of mTORC1 Signaling in T Cells | 1 | 2025 |
| R01AI160706 | Combined adjuvant approaches for enhancement of SARS-CoV-2 vaccine efficacy | 1 | 2025 |
| R01AI161017 | Activated NK CAR Cells to Cure HIV | 1 | 2025 |
| R01AI163029 | Inborn errors of immunity in patients with life-threatening COVID-19 | 1 | 2025 |
| R01AI167003 | In vivo engineering of B cells for the secretion of HIV broadly neutralizing antibodies | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/grants?page=11